BridgeBio Oncology Therapeutics Inc.
BBOT | NASDAQ
$4.67
+$0.01 (+0.21%)
Sep 22, 2026, 10:37 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 54.06M | 52.66M | 373.69M | 408.74M | 31.52M | 26.22M | 1.7M | 1.79M | 1.81M | 1.84M | n/a | n/a |
Short-Term Investments | 171.65M | 199.62M | 51.77M | 59.54M | 99.88M | 109.5M | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | 136.75M | 132K | n/a | n/a | n/a | 192.45M | 190.2M | 187.65M | 185.21M | n/a | n/a |
Other Long-Term Assets | 131.35M | 11.24M | 18.8M | 5.52M | 5.46M | 5.15M | 25.13K | 87.59K | 150.05K | 212.51K | 332.89K | 144.58K |
Receivables | n/a | 146K | 386K | 226K | 1.08M | 40K | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 16.67M | 14.08M | -386K | 7.5M | 5.58M | 5.57M | n/a | n/a | n/a | n/a | n/a | n/a |
Total Current Assets | 242.38M | 266.5M | 425.46M | 476.01M | 142.35M | 141.33M | 1.95M | 2.04M | 2.08M | 2.11M | n/a | n/a |
Property-Plant & Equipment | 2.98M | 3.16M | 3.29M | 3.27M | 3.45M | 3.36M | n/a | n/a | n/a | n/a | n/a | n/a |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 134.33M | 151.14M | 22.92M | 8.78M | 8.91M | 8.51M | 192.47M | 190.29M | 187.8M | 185.42M | 332.89K | 144.58K |
Total Assets | 376.71M | 417.65M | 448.38M | 484.79M | 151.25M | 149.84M | 194.42M | 192.33M | 189.87M | 187.53M | 332.89K | 144.58K |
Account Payables | 6.73M | 12.09M | 1.37M | 3.65M | 2.2M | 3.65M | n/a | n/a | n/a | n/a | n/a | n/a |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 554K | 538K | 522K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 70.1K | 43.4K |
Other Current Liabilities | 51.08M | 28.61M | 27.4M | 4.49M | 2.74M | 5.73M | n/a | 126.69K | n/a | n/a | n/a | n/a |
Total Current Liabilities | 51.63M | 43.26M | 35.04M | 35.71M | 27.25M | 24.06M | 187.52K | 126.69K | 79.14K | 23.33K | 396.46K | 166.46K |
Long-Term Debt | 1.96M | n/a | 2.24M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | 349.22M | 323.17M | 5.52M | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | 1.96M | 2.11M | 2.24M | 2.38M | 351.74M | 325.81M | 5.52M | 5.52M | 5.52M | 5.52M | n/a | n/a |
Total Liabilities | 53.59M | 45.37M | 37.29M | 38.09M | 378.99M | 349.87M | 5.71M | 5.65M | 5.6M | 5.54M | 396.46K | 166.46K |
Total Debt | 2.51M | 2.64M | 2.77M | 2.89M | 2.83M | 2.65M | n/a | n/a | n/a | n/a | 70.1K | 43.4K |
Book Value | 323.11M | 372.28M | 411.1M | 446.7M | -227.73M | -200.03M | 188.72M | 186.69M | 184.28M | 181.99M | -63.57K | -21.88K |
Book Value Per Share | 4.04K | 11.95 | 13.20 | 19 | -9.69 | -8.51 | 11.34 | 7.94 | 7.84 | 8.27 | 0 | 0 |
Common Stock | 8K | 8K | 8K | 8K | n/a | n/a | 192.45M | 190.2M | 187.65M | 185.21M | 460 | 288 |
Retained Earnings | -455.13M | -398.67M | -356.57M | -317.77M | -273.01M | -244.58M | -3.73M | -3.52M | -3.37M | -3.22M | -88.57K | -46.88K |
Comprehensive Income | -959K | -981K | 16K | 36K | 51K | 191K | n/a | n/a | n/a | n/a | n/a | n/a |
Shareholders Equity | 323.11M | 372.28M | 411.1M | 446.7M | -227.73M | -200.03M | 188.72M | 186.69M | 184.28M | 181.99M | -63.57K | -21.88K |
Total Investments | 171.65M | 336.37M | 51.91M | 59.54M | 99.88M | 109.5M | 192.45M | 190.2M | 187.65M | 185.21M | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove BBOT